Safety and Efficacy Study of AGS-004 During Analytical Treatment Interruption

NCT01069809 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infection

Interventions

BIOLOGICAL: AGS-004
BIOLOGICAL: Placebo

Sponsor

Argos Therapeutics